Christoph Lacroix: “Bifidobacteria are critical for microbiota development in infants”

Staff editor

26.01.2023

According to Christoph Lacroix (ETH Zurich), bifidobacteria are critical in the development of the neonatal microbiota. Here's why.

According to Christoph Lacroix (ETH Zurich), bifidobacteria are critical in the development of the neonatal microbiota. Here’s why.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Christoph Lacroix: “Bifidobacteria are critical for microbiota development in infants”

Latest related content

InnoGI Technologies: advancing gut microbiome research with mucus-enhanced models

NIST redefines gut microbiome research with breakthrough reference material

Gut microbes linked to inflammatory bowel diseases worsen colitis in mice

Sugary drinks may raise diabetes risk by altering gut bacteria

MaaT013 cleared for pediatric trials: EMA approval marks key milestone for microbiome therapy in aGvHD

Resetting the immune system: HMOs as a promising treatment for Gut-Brain Axis disorders

Latest News